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ABSTRACT
Stripping voltammetry (SV) is used to quantitatively determine concentrations of the anti-neoplastic drug
mitomycin C (MMC) alone and in mixtures with 5-fluorouracil and cisplatin, both of which are used in
combined chemotherapy with MMC. If the accumulation is performed at the potentials of MMC reduction
(-0.35 V vs. SCE), reduced MMC is strongly adsorbed at the electrode. It is possible to prepare a MMC-
modified electrode, which, after a washing step, is transferred to the background electrolyte to determine
MMC by voltammetry. This procedure, which is termed transfer stripping voltammetry (TSV), helps to
eliminate interferences and can be applied for a direct determination of MMC alone or in mixtures with other
drugs in urine.
INTRODUCTION
The determination of the antibiotic mitomycin C (MMC) in aqueous solutions and in biological fluids has
been a subject of special interest in several papers (reviewed in (1)) because MMC is an anti-neoplastic drug
widely used in clinical chemotherapy. The anti-cancer activity of MMC is based on its covalent binding to
DNA (2) after chemical or enzymatic reductive activation. This reductive activation is a complex process
involving reduction of the quinone group and opening of the aziridine ring. These processes occur at the
hanging mercury drop electrode (HMDE) (3). In a previous paper (4), we reported that stripping
voltammetry (SV) of MMC at the accumulation potentials corresponding to MMC reduction (between -0.3
and -0.4 V vs SCE) produces a useful analytical signal in aqueous solutions. Also, at these accumulation
potentials, MMC is so strongly adsorbed at the mercury electrode that the MMC layer can be washed and
transferred to the electrolyte (not containing any dissolved MMC), where it produces a response similar to
that obtained with the electrode immersed in the MMC solution. This method, termed transfer stripping
voltammetry (TSV), is useful for MMC determination in biological fluids containing interfering substances
that are either not adsorbed at the electrode or that are separated in the washing step.
MATERIALS AND METHODS
Apparatus
Voltammetric measurements were carried out with an Amel 473 multipolarograph analyzer connected to
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an Amel 863 XY recorder with time-base. As a working electrode, a Metrohm (6.0335.000) hanging
mercury drop electrode (HMDE) was used with a drop area of 1.39 mm . A saturated calomel electrode2
(SCE) and a platinum electrode, both from Ingold, were used as reference and auxiliary electrodes
respectively. All measurements were carried out in a nitrogen atmosphere at room temperature. The pH
values were measured with a Radiometer pH meter model 62.
Reagents
MMC was received from Merck. 5-fluorouracil (5-FU) was from Sigma. Cisplatin (cis-Pt) was from
Farmitalia (Barcelona, Spain). Other chemicals were purchased from Merck and were of analytical grade.
Urine samples containing MMC and other anti-neoplastic drugs were prepared by dissolving the appropriate
quantity of the drug in urine specimens obtained from healthy volunteers. No sample treatment steps were
performed, except for a urine dilution (1:3) with the background electrolyte. Voltammograms of urine
obtained from different healthy individuals did not show substantial differences.
A solution consisting of 0.3 M ammonium formate, 50 mM sodium phosphate, pH 6.9 (AFP) was used as
the background electrolyte, because it is suitable for measurements of the cathodic response of MMC (4),
and also for measurements of the DNA signals (5,6), which allows for future study of the interaction of
MMC with DNA. Wang et al. (7) used 0.025 M boric acid solution, adjusted to pH 10.2 with sodium
hydroxide as supporting electrolyte in the MMC determination by means of stripping voltammetry.
Considering the poor stability of MMC outside the pH range 5-8 (8), using the above neutral AFP solution
allowed us to obtain reproducible results even after storing the MMC solution at room temperature for
periods as long as one day. On the other hand, when we used the previously applied alkaline medium (pH
10.2), the MMC peak used for analytical purposes decreased with time. In 2.5 h, this peak current decreased
by 60%.
Stripping Voltammetry (SV)
SV is an extremely sensitive electrochemical technique in which the substance is preconcentrated by
electrodeposition at a controlled time and potential into a small-volume electrode. The substance of interest
can be measured at concentration levels down to 10 M. Its remarkable sensitivity is attributed to the-10
combination of an effective preconcentration step with advanced measurement procedures that generate an
extremely favorable signal-to-background ratio.
In the MMC analysis by SV, an accumulation potential of -0.35 V was applied to a fresh mercury drop
immersed in the solution containing MMC alone (or in mixture with 5-FU or cis-Pt), stirring the solution
at 500 rpm during the accumulation period (usually 3 min was long enough to fully cover the electrode and
to ensure good reproducibility.) Stirring and accumulation were then stopped and the initial potential was
applied for 15 s, after which the voltammograms were recorded at the following settings (if not stated
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Fig. 1: Scheme for TSV.
Transfer Stripping Voltammetry (TSV)
This technique was developed in the late 1980's (9,10) to determine sub-nanogram quantities of nucleic
acids (NA) exploiting the strong affinity of NA for the mercury and carbon electrodes (11,12).
Attachment of low molecular mass substances such as MMC to the mercury electrode has rarely been
observed. However, we observed a strong immobilization of MMC at the HMDE when applied potentials
corresponded to the MMC reduction (between -0.3 and -0.4 V vs. SCE), making possible the easy
preparation of a MMC-modified electrode. Such a modified electrode is used in MMC analysis in mixtures
containing other substances which are not strongly attached to the electrode under the given conditions and
which would otherwise interfere with the determination of MMC in conventional voltammetric analysis, as
occurs with the MMC determination in urine samples.
In TSV of urine samples containing MMC and its
mixtures with 5-FU or cis-Pt, the HMDE was
immersed in the solution at an accumulation
potential of -0.35 V for an accumulation time of 5
min without stirring (urine samples produce foam
with stirring, and the electrode surface is partially
blocked, causing the MMC signals to be weaker
and not as well defined as those obtained without
stirring). The electrode was then removed from
the solution and washed (nitrogen was passed
through the washing medium) with distilled water
for 15 s (to eliminate interfering substances) and
with the background electrolyte for 15s (to keep
the electrolyte concentration in the voltammetric
cell constant.) The electrode was finally placed in
t h e voltammetric cell with a previously
deoxygenated background electrolyte (not containing any dissolved drug) and nitrogen was bubbled again
through the solution for 120 s to remove the oxygen introduced in the process of transferring the HMDE.
The circuit was closed and following the application of the initial potential for 15 s, the voltammetric
measurement was taken at the same settings as in SV. The whole procedure is shown in Fig. 1.
The transfer procedure was performed with a round carousel containing holes designed according to the
diameter of the washing vessels and cells (Fig. 2). The carousel is joined to a lever, allowing the vessels or
cells to be raised or lowered. The electrodes are placed above the carousel. Thus, the electrodes are
immersed in the desired solution when the carousel is “up” and are removed from the solution when the
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Fig. 2: Carousel used to perform the TSV experiments.
carousel is “down.” Revolving the carousel
transfers the electrodes through the solutions
in a chosen order.
Determining MMC by TSV made it possible:
(a) to adsorb MMC at the HMDE from
media not suitable for conventional
voltammetric analysis and to perform the
electrochemical measurements in the medium
of choice (i.e. AFP); (b) to exploit the
differences in the adsorbability of MMC and
other substances to separate them at the
electrode in the washing step; (c) to study the
influence of the electrode potential on MMC
signals; (d) to study the interaction of
immobilized MMC with other substances as
DNA, since it is known that MMC interacts
with guanine residues in DNA.
For substances accumulated at the electrode surface by adsorption that do not require any accumulation
potential (i.e. DNA), the modified electrode can be prepared by immersing the electrode in a drop of the
substance at open circuit. This method is called Adsorption Transfer Stripping Voltammetry (AdTSV).
Using 5-10 µL drops makes it possible to reduce the volume of the analyzed sample by two orders of
magnitude as compared to the conventional voltammetric experiments.
RESULTS AND DISCUSSION
Determination of MMC in aqueous solutions by using SV
Conventional voltammetry of MMC solutions in AFP yields two reversible cathodic peaks at -0.31 and -0.43
V (peaks Ic and IIc). SV responses are highly influenced by the accumulation potential (E ) (4). At E lessA A
negative than -0.3 V (corresponding to reduction of the MMC quinone moiety which caused the peak I ),c
both peaks were obtained. However, at E between -0.3 and -0.4 V, only the peak II appeared. This peakA c
was chosen for analytical purposes, thus E -0.35 V was selected for the determination of MMC.A
Using concentrations of MMC of 9x10 M, increasing the accumulation time (t ), resulted in peak II-7 A c
showing a linear dependence up to 3 min (stirring at 500 rpm); at longer t , linear dependence leveled off.A
Stirring resulted in a 3-fold enhancement of the response, hence indicating the fast rate of adsorption on the
electrode surface. The proposed idealized conditions for determining MMC in AFP solutions are then EA
of -0.35 V, and t at 3 min (stirring at 500 rpm).A
MMC gave a linear calibration for the concentration range 1-20x10 M (1x10 M corresponds to 3.34 ng-8 -8
ml ). Deviations from linearity were obtained at higher concentrations, where the electrode surface was-1
saturated. Further data are summarized in Table 1.
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Mixtures of MMC with other anti-neoplasic drugs used in combined chemotherapy (13) were tested by
using SV. Doxorubicin, vinblastine, bleomycin and vincristine produced their own signals at submicromolar
level. 5-Fluorouracil (5-FU) produced no peak in the studied potential range and cisplatin (cis-Pt) showed
only a little peak at -0.52 V. The MMC calibration curves were done in mixtures MMC and 5-FU, and
MMC and cis-Pt, and the same results as in MMC alone were obtained. Similar experiments were performed
with 5 µM MMC, 5-FU and cis-Pt concentrations varying between 10 and 75 µM, and no differences in the
MMC peak current were observed.
These results show that SV (at E -0.35 V, t 3 min, stirring at 500 rpm) is suitable to determine MMC inA A
an excess of 5-FU and cis-Pt.
Determination of MMC in urine samples by using TSV
Attempts to determine MMC in urine (diluted 4-fold by AFP) by conventional SV were not successful
because urine samples alone produced peaks in the potential region close to the MMC peak. This
interference of urine was efficiently eliminated by TSV in which MMC was adsorbed at the electrode by
applying an accumulation potential of -0.35 V followed by washing, medium exchange and determining
MMC immobilized at the electrode in a blank background electrolyte.
A comparison of the measurements with and without stirring of the analyte during the accumulation time
showed that the MMC signal is better and of higher amplitude without stirring. With 1 µM MMC, the
electrode surface was fully covered at the accumulation time (t ) of 5 min, without stirring. ReproducibilityA
suffers when the electrode is not covered fully. Optimal conditions for MMC analysis in urine were t 5 min,A
E -0.35 V, without stirring. A linear relationship of the peak was observed in the range 3-30x10 M,A -7
corresponding to 100-1000 ng ml . Additional data are shown in Table 1. The voltammograms did not show-1
any difference by comparing the urine samples spiked with MMC alone, MMC and 5-FU or MMC and cis-
Pt. The MMC calibration curves were performed in these mixtures and the same results as in MMC alone
were obtained.
Table 1: Mitomycin C calibration curves in aqueous solutions (using SV) and in urine (using TSV) in
both cases as much alone as in mixtures with 5-fluorouracil or cisplatin
Aqueous solutions  Urine
linearity over range (ng ml ) 3-70 100-1000-1
slope. 10 (µA/ng ml ) 13.6 1.204 -1
standard deviation of the slope.10 0.2 0.024
intercept (µA) 0.002 0.000
standard deviation of the intercept 0.001 0.001
correlation coefficient 0.9988 0.9992
detection limit. (ng ml ) 3 30-1
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Quantitatively, the MMC peak was lower in urine than in pure aqueous solutions. This might be partly due
to adsorption of surface-active urine components (resistant to washing) at the electrode surface. This effect
produces a 10-fold decrease in sensitivity (slope) upon changing the adsorption medium from water to urine,
but does not affect the accuracy of the measurement, since urine specimens of different healthy volunteers
yield the same calibration curve, indicating that the signal is independent of the urine matrix.
Although the detection limit (100 ng ml ) is higher than the previously obtained by Tjaden et al. (1 ng ml )-1 -1
by HPLC with on-line sample pre-treatment (14), the TSV determination of MMC alone and in the presence
of other drugs in urine proposed in this paper is sufficiently sensitive to be of potential use in the clinical
analysis, since the concentrations of MMC in urine of clinical patients range between 500-1000 ng ml (14)-1
while those of 5-FU (15,16) and cis-Pt (17) usually exceed 2000 and 750 ng ml , respectively. The main-1
advantage of the technique proposed here is that in variance to HPLC and other methods, where it is
mandatory to isolate the drug from the biological matrix, usually by solvent or solid phase extraction, the
MMC determination in urine described here is very simple and does not require urine pre-treatment. Most
interfering substances present in urine samples are either not adsorbed at the electrode or are separated in
the washing step, if their adsorption at the electrode is weaker than the attachment of MMC to the surface.
The TSV determination of MMC is rapid and inexpensive and may become the method of choice for MMC
determination in patients.
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